Electromagnetic Therapy
Alzheimer’s Research Initiative
REMFS LLC aims to develop a noninvasive therapy utilizing electromagnetic radiation at 64 MHz to reduce toxic aβ levels in Alzheimer’s patients, collaborating with Indiana University and Purdue University.
Phase One Results
The initial phase was conducted at Indiana University School of Medicine, focusing on PHB cultures to assess the efficacy of electromagnetic field stimulation in reducing aβ levels.
Innovative Design
The second phase at Purdue University involved creating a portable birdcage design using a meander line antenna, optimizing penetration depth and power deposition across memory brain areas in numerical models.
Innovative Therapy Solutions
At REMFS LLC, we are pioneering a noninvasive electromagnetic therapy to combat Alzheimer’s by reducing toxic aβ levels through advanced research and collaboration.
Innovative Therapy
Exploring noninvasive REMFS technology to alleviate Alzheimer’s disease through electromagnetic stimulation.
